Anthem Biosciences Ltd (ANTHEM)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 823.50
% Change: 0.61% (Prev Close: 818.50)

Volume: 2,45,748
% Change: -19.27% (Prev Volume: 3,04,414)

Delivery: 86,316
Delivery % : 35.12
% Change: -28.21% (Prev Delivery: 1,20,242)

Turnover: 2,015 Lacs
% Change: -19.65% (Prev Turnover: 2,508)

💹 EOD Valuation

P/E Ratio: 102.04
P/B Ratio: 0.00
Market Cap: 46248 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: ANTHEM
Market Cap: 45943 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 865.00
52 Week Low: 701.75

All-Time High: 865.00 Rs.
All-Time Low: 701.75 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
11.80% | 0.00% | 0.00% | 0.00% | 0.00%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 74.69%

Change (3Y | 1Y): 0.00% | -2.54%

Pledged %: 0.00%

FII Holding

FII Holding: 1.50%

Change (3Y | 1Y): 0.00% | 0.00%

DII Holding

DII Holding: 3.60%

Change (3Y | 1Y): 0.00% | 0.00%

Public Holding: 20.20%


🏦 Financial Strength

Debt to Equity: 0.05
Debt: 113.32 Rs. Cr.

Book Value: 0.00 Rs.
Current Ratio: 4.05
Interest Coverage: 63.42
Free Cash Flow: 153.76 Rs. Cr.


📈 Growth & Sales

Sales Growth: 29.96%

Sales Growth Qtr (YOY | QoQ):
59.55% | 11.80%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
23.86% | 14.42% | 29.96%


💰 Profit & Earnings

Profit Growth %

Profit Growth: 22.85%

Profit Growth Qtr (YOY | QoQ):
64.83% | 64.35%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
37.27% | 3.63% | 22.85%


EPS Rs.

EPS (TTM): 8.07 Rs.

EPS Qtr (Last Year | Latest):
1.47 Rs. | 2.42 Rs.

EPS Annual (Last Annual | Annual March):
6.57 Rs. | 8.07 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-40.74% | -74.05%


Net Profit Rs. Cr.

Net Profit (TTM): 451.26 Rs. Cr.

Net Profit (Annual - March): 451.26 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
82.38| 82.62 | 135.79


EBITDA Rs. Cr.

EBITDA (Quarter): 214.30 Rs. Cr.
EBITDA (Previous Yr Ql): 140.36 Rs. Cr.

EBITDA (Annual - March): 757.13 Rs. Cr.
EBITDA (Previous Annual): 569.09 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
30.17% | 7.22%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 36.40%

OPM Qtr (Previous | Current):
40.40% | 35.45%

OPM Annual (5 Yrs | Last Yr | March):
38.78% | 35.62% | 36.40%


Return on Equity %

ROE: 20.83%

ROE (5 Yrs | 3 Yrs | Last Yr):
25.79% | 20.97% | 20.05%


Return on Capital Employed %

ROCE: 28.50%

ROCE (5 Yrs | 3 Yrs | Last Yr):
37.32% | 26.81% | 24.18%


Return on Assets %

ROA (TTM): 17.35%

ROA (5 Yrs | 3 Yrs | Last Yr):
22.67% | 17.65% | 16.66%



PEG Ratio: 28.03
Dividend Yield: 0.00%

PE 3 Yrs: 94.67
PE 5 Yrs: 94.67

Dividend Yield: 0.00%


👥 Company

Anthem Biosciences Ltd

ANTHEM

Promoter Holding: %